SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Derksen, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Derksen, R.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Clinical manifestations and management of the antiphospholipid syndrome

Rhwm Derksen

Department Internal Medicine (F02.126), Section Clinical Immunology and Infectious Diseases, University Hospital Utrecht, PO Box 85500, 3508 GA Utrecht

Since the original description of associations between lupus anticoagulant and anti cardiolipin antibodies with thrombosis, fetal loss and thrombocytopenia, several distinct clinical manifestations related to this so-called antiphospholipid syndrome have appeared in the literature. Retrospective studies indicate that long-term treatment with oral anticoagu lants can effectively reduce the chance of recurrent thrombosis. However, data from con trolled prospective studies are urgently needed to enable optimal counselling of patients suffering from this syndrome.

Key Words: antiphospholipid syndrome • lupus anticoagulant • anticardiolipin antibodies

Lupus, Vol. 5, No. 2, 167-169 (1996)
DOI: 10.1177/096120339600500217
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 RadioGraphicsHome page
S. E. Rha, H. K. Ha, S.-H. Lee, J.-H. Kim, J.-K. Kim, J. H. Kim, P. N. Kim, M.-G. Lee, and Y.-H. Auh
CT and MR Imaging Findings of Bowel Ischemia from Various Primary Causes
RadioGraphics, January 1, 2000; 20(1): 29 - 42.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
H. G. Rennke and M. Laposata
Case 18-1999- A 54-Year-Old Woman with Acute Renal Failure and Thrombocytopenia
N. Engl. J. Med., June 17, 1999; 340(24): 1900 - 1908.
[Full Text] [PDF]

Home page
 LupusHome page
D. Giorgi and F. Vaccaro
Vaso-occlusive retinopathy: is it a classical clinical manifestation of the antiphospholipid syndrome?
Lupus, January 1, 1997; 6(7): 617 - 617.
[PDF]

Home page
 LupusHome page
R. Derksen
Reply to letter by Dr Giorgi
Lupus, January 1, 1997; 6(7): 618 - 618.
[PDF]


Advertisement